Takeru Kashiwada

963 total citations
36 papers, 429 citations indexed

About

Takeru Kashiwada is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Takeru Kashiwada has authored 36 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Takeru Kashiwada's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (17 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Lung Cancer Treatments and Mutations (7 papers). Takeru Kashiwada is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (17 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Lung Cancer Treatments and Mutations (7 papers). Takeru Kashiwada collaborates with scholars based in Japan, United States and Czechia. Takeru Kashiwada's co-authors include Akihiko Gemma, Yoshinobu Saito, Masahiro Seike, Kaoru Kubota, Hiroki Hayashi, Arata Azuma, Koichiro Kamio, Kuniko Matsuda, Jiro Usuki and Minoru Inomata and has published in prestigious journals such as SHILAP Revista de lepidopterología, Development and Scientific Reports.

In The Last Decade

Takeru Kashiwada

32 papers receiving 418 citations

Peers

Countries citing papers authored by Takeru Kashiwada

Since Specialization

Citations

This map shows the geographic impact of Takeru Kashiwada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeru Kashiwada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeru Kashiwada more than expected).

Fields of papers citing papers by Takeru Kashiwada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeru Kashiwada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeru Kashiwada. The network helps show where Takeru Kashiwada may publish in the future.

Co-authorship network of co-authors of Takeru Kashiwada

This figure shows the co-authorship network connecting the top 25 collaborators of Takeru Kashiwada. A scholar is included among the top collaborators of Takeru Kashiwada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeru Kashiwada. Takeru Kashiwada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Direct hemoperfusion with polymyxin B immobilized fiber column (PMX) treatment for acute exacerbation of idiopathic pulmonary fibrosis: A prospective multicenter cohort study 2024 ·Respiratory Investigation ·Shinji Abe, Arata Azuma, Yoshinobu Saito, Hiroki Hayashi, Takeru Kashiwada, Toru Tanaka, Tomohisa Baba, Akimasa Sekine, Hideya Kitamura, Ryo Okuda, Satoshi Ikeda, Takashi Ogura	0
2	Clinical course of COPD patients with exercise-induced elevation of pulmonary artery pressure or less severe pulmonary hypertension presenting with respiratory symptoms and the impact of bosentan intervention—prospective, single-center, randomized, parallel-group study 2024 ·BMC Pulmonary Medicine ·Takeru Kashiwada, Yosuke Tanaka, Toru Tanaka, Tetsuya Okano, Yoshinobu Saito, Masahiro Seike, Mitsunori Hino, Hiroshi Kimura, Akihiko Gemma	0
3	Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancer 2024 ·Frontiers in Pharmacology ·(unknown), Takeru Kashiwada, Shoko Kuroda, Takenori Fujii, (unknown), Yoshishige Miyabe, Shinobu Kunugi, Takashi Sakatani, Akihiko Miyanaga, Tomoko Asatsuma‐Okumura, Masaaki Hashiguchi, Yoshikazu Kanazawa, Ryuji Ohashi, Hiroshi Yoshida, Masahiro Seike, Akihiko Gemma, Yoshiko Iwai	4
4	Bortezomib induces Rho-dependent hyperpermeability of endothelial cells synergistically with inflammatory mediators 2024 ·BMC Pulmonary Medicine ·(unknown), Takeru Kashiwada, Yoshinobu Saito, Shinya Yuge, (unknown), Kuniko Matsuda, Koichiro Kamio, Masahiro Seike, Shigetomo Fukuhara, Akihiko Gemma	0
5	Lysosomal degradation of PD-L1 is associated with immune-related adverse events during anti-PD-L1 immunotherapy in NSCLC patients 2024 ·Frontiers in Pharmacology ·Takeru Kashiwada, (unknown), (unknown), Shoko Kuroda, Yoshishige Miyabe, (unknown), Akihiko Miyanaga, Tomoko Asatsuma‐Okumura, Masaaki Hashiguchi, Yoshikazu Kanazawa, Hiroshi Yoshida, Masahiro Seike, Akihiko Gemma, Yoshiko Iwai	4
6	Clinicopathological Characteristics of Everolimus-Associated Interstitial Lung Disease: A Single-Center Consecutive Analysis 2024 ·Journal of Nippon Medical School ·Yoshinobu Saito, Yasuhiro Terasaki, Takeru Kashiwada, (unknown), Hiroyuki Takei, Go Kimura, Yukihiro Kondo, Tetsuro Kawagoe, Akira Matsushita, Rintaro Noro, Yuji Minegishi, Koichiro Kamio, Masahiro Seike, Akihiko Gemma	1
7	Identification and characterization of lysophosphatidylcholine 14:0 as a biomarker for drug-induced lung disease 2022 ·Scientific Reports ·Kosuke Saito, Akihiko Gemma, Koichiro Tatsumi, Noboru Hattori, Atsuhito Ushiki, Kenji Tsushima, Yoshinobu Saito, Mitsuhiro Abe, Yasushi Horimasu, Takeru Kashiwada, Kazuhiko Mori, (unknown), (unknown), (unknown), Yuchen Sun, Noriaki Arakawa, Takashi Izumi, Yasuo Ohno, Yoshiro Saito, Masayuki Hanaoka	12
8	Effect of Adding Inhaled Corticosteroid to Long-Acting Muscarinic Antagonist/Long-Acting Beta-Agonist Therapy Among Patients With Chronic Obstructive Pulmonary Disease 2021 ·Cureus ·(unknown), Yosuke Tanaka, Tohru Tanaka, Takeru Kashiwada, (unknown), Yoshinobu Saito, Masahiro Seike, Mitsunori Hino, Akihiko Gemma	1
9	Rictor-targeting exosomal microRNA-16 ameliorates lung fibrosis by inhibiting the mTORC2-SPARC axis 2020 ·Experimental Cell Research ·Minoru Inomata, Koichiro Kamio, Arata Azuma, Kuniko Matsuda, Jiro Usuki, (unknown), Toru Tanaka, Takeru Kashiwada, (unknown), Hiroki Hayashi, Kazue Fujita, Yoshinobu Saito, Kaoru Kubota, Masahiro Seike, Akihiko Gemma	14
10	Successful Treatment with Afatinib after Osimertinib-induced Interstitial Lung Disease in a Patient with EGFR-mutant Non-small-cell Lung Cancer 2020 ·Internal Medicine ·(unknown), Akihiko Miyanaga, (unknown), (unknown), Satoshi Takahashi, Takeru Kashiwada, Teppei Sugano, Rintaro Noro, Yuji Minegishi, Yasuhiro Terasaki, Yoshinobu Saito, Kaoru Kubota, Masahiro Seike, Akihiko Gemma	9
11	Spontaneous pulmonary hematoma with diffuse pulmonary ossification requiring emergency treatment: a case report 2019 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Tatsuya Inoue, Takeru Kashiwada, Yasuhiro Terasaki, Jitsuo Usuda	3
12	Anti-MDA5 antibody-positive rapidly progressive interstitial pneumonia without cutaneous manifestations 2019 ·Respiratory Medicine Case Reports ·(unknown), Hiroki Hayashi, (unknown), Hiroyuki Takoi, Toru Tanaka, Takeru Kashiwada, Nariaki Kokuho, Yasuhiro Terasaki, (unknown), Takahisa Gono, Masataka Kuwana, Yoshinobu Saito, Shinji Abe, Masahiro Seike, Akihiko Gemma	11
13	A case of interstitial lung disease with alveolar hemorrhage induced by pembrolizumab 2018 ·OncoTargets and Therapy ·Teppei Sugano, Masahiro Seike, Rintaro Noro, (unknown), Takehiro Tozuka, Akihiko Takahashi, (unknown), Toru Tanaka, Takeru Kashiwada, Susumu Takeuchi, Yuji Minegishi, Yoshinobu Saito, Kaoru Kubota, Yasuhiro Terasaki, Akihiko Gemma	9
14	Pulmonary embolism and deep vein thrombosis in eosinophilic granulomatosis with polyangiitis successfully treated with rivaroxaban 2018 ·Respiratory Medicine Case Reports ·Tomoyuki Naito, Hiroki Hayashi, Takeru Kashiwada, Yoshinobu Saito, Shinji Abe, Kaoru Kubota, Akihiko Gemma	3
15	Pembrolizumab and salvage chemotherapy in EGFR T790M-positive non-small-cell lung cancer with high PD-L1 expression 2018 ·OncoTargets and Therapy ·Takehiro Tozuka, Masahiro Seike, Yuji Minegishi, Shingo Kitagawa, Tomomi Kato, (unknown), Kakeru Hisakane, Satoshi Takahashi, Kenichi Kobayashi, Takeru Kashiwada, Teppei Sugano, Susumu Takeuchi, Shinobu Kunugi, Rintaro Noro, Yoshinobu Saito, Kaoru Kubota, Akihiko Gemma	5
16	Resolution of bleomycin-induced murine pulmonary fibrosis via a splenic lymphocyte subpopulation 2018 ·Respiratory Research ·Koichiro Kamio, Arata Azuma, Kuniko Matsuda, Jiro Usuki, Minoru Inomata, (unknown), Takeru Kashiwada, Nobuhiko Nishijima, (unknown), Nariaki Kokuho, (unknown), Hiroki Hayashi, (unknown), Kazue Fujita, Yoshinobu Saito, Shinji Abe, Kaoru Kubota, Akihiko Gemma	37
17	Granuloma-forming interstitial pneumonia induced by nivolumab: a possible immune-related adverse event of the lung 2017 ·International Cancer Conference Journal ·Takeru Kashiwada, Yoshinobu Saito, Yuji Minegishi, Nariaki Kokuho, Akihiko Takahashi, Satoshi Takahashi, (unknown), Masahiro Seike, Arata Azuma, Kaoru Kubota, Yasuhiro Terasaki, Akihiko Gemma	4
18	XPLN is modulated by HDAC inhibitors and negatively regulates SPARC expression by targeting mTORC2 in human lung fibroblasts 2017 ·Pulmonary Pharmacology & Therapeutics ·Koichiro Kamio, Arata Azuma, Jiro Usuki, Kuniko Matsuda, Minoru Inomata, Nobuhiko Nishijima, (unknown), Hiroki Hayashi, Takeru Kashiwada, Nariaki Kokuho, (unknown), (unknown), Kazue Fujita, Yoshinobu Saito, Shinji Abe, Kaoru Kubota, Akihiko Gemma	15
19	The parallel growth of motoneuron axons with the dorsal aorta depends on Vegfc/Vegfr3 signaling in zebrafish 2013 ·Development ·(unknown), Shigetomo Fukuhara, Kazuhide Asakawa, Koji Ando, Takeru Kashiwada, Koichi Kawakami, Masahiko Hibi, Young‐Guen Kwon, Kyu-Won Kim, Kari Alitalo, Naoki Mochizuki	34
20	A novel interaction between fibroblast growth factor receptor 3 and the p85 subunit of phosphoinositide 3-kinase: activation-dependent regulation of ERK by p85 in multiple myeloma cells 2009 ·Human Molecular Genetics ·(unknown), Takeru Kashiwada, Pavel Krejčı́, Paul J. Muchowski, Dan Donoghue, William R. Wilcox, Leslie M. Thompson	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact